Culturally Adapting CBT for East Asian Youth in Ontario
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03711344 |
|
Recruitment Status : Unknown
Verified January 2019 by Centre for Addiction and Mental Health.
Recruitment status was: Recruiting
First Posted : October 18, 2018
Last Update Posted : February 1, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Anxiety Depression | Behavioral: Cognitive Behavioral Therapy | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 36 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | East Asian youth diagnosed with Anxiety and/or depression will be randomly assigned to either the experimental group (receives the cultural adapted version of cognitive behavioral therapy) or the control group (non-culturally adapted cognitive behavioral therapy). It is a randomized control trial design. |
| Masking: | Single (Outcomes Assessor) |
| Primary Purpose: | Treatment |
| Official Title: | Improving Access to High Quality, Culturally Relevant Treatment for East Asian Canadian Youth in Ontario |
| Actual Study Start Date : | January 4, 2019 |
| Estimated Primary Completion Date : | September 18, 2019 |
| Estimated Study Completion Date : | September 18, 2019 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Culturally adapted Cognitive Behavioral therapy
The experimental group will receive the culturally adapted version of cognitive behavioral therapy.
|
Behavioral: Cognitive Behavioral Therapy
The intervention will be administered by therapists working at community agencies who are experienced at providing Cognitive Behavioral Therapy. |
|
Active Comparator: Non-adapted Cognitive Behavioral therapy
The control group will receive the original (non-adapted) version of cognitive behavioral therapy.
|
Behavioral: Cognitive Behavioral Therapy
The intervention will be administered by therapists working at community agencies who are experienced at providing Cognitive Behavioral Therapy. |
- Severity levels of depression and anxiety rated by the Hospital Anxiety and Depression Scale (HADS). [ Time Frame: 4 months. ]Severity levels of depression and anxiety will be rated pre- and post-intervention by the Hospital Anxiety and Depression Scale (HADS). The scale ranges from 0 to 21 for anxiety and 0 to 21 for depression. A score of 0 to 7 for depression and/or anxiety is considered a normal range. A score of 8 to 10 suggests the potential presence of depression and/or anxiety. A score of 11 or more suggests a likely presence of depression and/or anxiety.
- Severity levels of depression and anxiety rated by the Bradford Somatic Inventory (BSI). [ Time Frame: 4 months. ]Severity levels of depression and anxiety will be rated pre- and post-intervention by the Bradford Somatic Inventory (BSI). The Bradford Somatic Inventory uses "yes" or "no" questions relating to somatic symptoms of anxiety and/or depression. A "yes" response to a question equates to a somatic symptom linked to depression and/or anxiety. The maximum number of "yes" responses is 46 and the minimum is 0. A higher number of "yes" responses suggests a potential increase in the severity of depression and/or anxiety.
- Satisfaction of the culturally adapted Cognitive Behavioral Therapy assessed using the Verona Satisfaction Scale. [ Time Frame: 4 months. ]Satisfaction will be measured using the Verona Satisfaction Scale. This scale measures patients satisfaction with health care services. The items are rated by 4 categories labelled: "strongly disagree", "disagree", "agree", and "strongly agree", on a scale of 1 to 4. A higher sub-scale/domain score indicates better satisfaction. All sub-scales are summed up to compute total/domain score. This scale will be used to identify the strengths and weaknesses of the therapy service and provide guidance for further development.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 12 Years to 21 Years (Child, Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Self identification as East Asian origin
- Between the ages of 12 to 21
- Diagnosed as having depression and/or anxiety
Exclusion Criteria:
- Have been affected by psychosis
- Have been affected by serious addiction
- Have been affected by cognitive impairment
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03711344
| Contact: Myra Levy | 416-438-3697 ext 12243 | mlevy@emys.on.ca | |
| Contact: Sireesha Bobbili, MPH | 416-535-8501 ext 36573 | Sireesha.Bobbili@camh.ca |
| Canada, Ontario | |
| East Metro Youth Services | Recruiting |
| Scarborough, Ontario, Canada, M1H 3C3 | |
| Contact: Myra Levy 4164383697 ext 12243 mlevy@emys.on.ca | |
| Contact: Arlene GonashNelson agonashnelson@emys.on.ca | |
| Principal Investigator: Farooq Naeem, PhD/MD | |
| Principal Investigator: | Farooq Naeem, M.D. | Centre for Addiction and Mental Health | |
| Study Director: | Myra Levy, M.A. | East Metro Youth Services |
| Responsible Party: | Centre for Addiction and Mental Health |
| ClinicalTrials.gov Identifier: | NCT03711344 |
| Other Study ID Numbers: |
innovation-1927 |
| First Posted: | October 18, 2018 Key Record Dates |
| Last Update Posted: | February 1, 2019 |
| Last Verified: | January 2019 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Cognitive Behavioral Therapy Cultural Adaptation East Asian Youth |
|
Depression Behavioral Symptoms |

